Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study. | J Clin Aesthet Dermatol;15(10): 58-61, 2022 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Oral Zinc as a Novel Adjuvant and Sparing Therapy for Systemic Isotretinoin in Acne Vulgaris: A Preliminary Comparative Study.

Salah, Eman.

Affiliation

Salah E; Dr. Salah is an Assistant Professor of Dermatology, Venereology and Andrology at Zagazig University in Zagazig, Egypt.

J Clin Aesthet Dermatol ; 15(10): 58-61, 2022 Oct.

Article in En | MEDLINE | ID: mdl-36312827

Key words

Acne vulgaris; isotretinoin; sebaceous glands; zinc

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Aesthet Dermatol Year: 2022 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Aesthet Dermatol Year: 2022 Document type: Article Affiliation country: Country of publication: